Albert Kildani

Albert Kildani

Investor Relations Contact chez ACADIA PHARMACEUTICALS INC.
Health Technology
Finance
Consumer Services

Profil

Albert S.
Kildani
is currently SVP-Investor Relations & Corporate Communications at ACADIA Pharmaceuticals, Inc. since 2023 and a Member of the National Investor Relations Institute.
Former positions include Senior Director-Investor Relations at Hologic, Inc. from 2012 to 2014; Senior Director-Investor Relations at Gen-Probe, Inc.; Director at SF Capital Group LLC from 2004 to 2009; Managing Director at Global Hunter Securities LLC from 2010 to 2011; VP-Investor Relations & Corporate Communications at Halozyme Therapeutics, Inc.; and VP-Investor Relations & Business Development at Vital Therapies, Inc. from 2014 to 2018.
Education includes undergraduate studies at Boston College.

Postes actifs de Albert Kildani

SociétésPosteDébut
ACADIA PHARMACEUTICALS INC. Investor Relations Contact 19/09/2023
Corporate Officer/Principal -

Anciens postes connus de Albert Kildani

SociétésPosteFin
Investor Relations Contact 01/09/2018
HOLOGIC, INC. Public Communications Contact 01/08/2014
Corporate Officer/Principal 01/01/2011
Directeur/Membre du Conseil 01/01/2009
HALOZYME THERAPEUTICS, INC. Investor Relations Contact -
Voir l'expérience en détail de Albert Kildani

Formation de Albert Kildani

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

69

Relations au 1er degré

9

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées9

Health Technology

Health Technology

Health Technology

Health Technology

Finance

Health Technology

Consumer Services

Finance

Commercial Services

  1. Bourse
  2. Insiders
  3. Albert Kildani